GlassScriptPhysician profile
Daniel R Feldman
NPI 1871084764
$16,547.21
in general payments reported to CMS, 2019-2025
5 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $59.22 · 2024: $2,937 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $12K · Travel and Lodging: $2,368 · Food and Beverage: $2,288 · Education: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $11,666.00 |
| Travel and Lodging | $2,368.01 |
| Food and Beverage | $2,287.86 |
| Education | $225.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,556.93 | 2024-2025 | General - Brady, Watchman Access System, Accolade Sr |
| Medtronic, INC. | $5,597.68 | 2024-2025 | Selectsecure, Evera Mri Xt Dr Surescan |
| Biotronik INC. | $135.90 | 2025 | |
| Abbott Laboratories | $134.99 | 2024 | Ensite |
| Astrazeneca Pharmaceuticals LP | $121.71 | 2023-2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.